Prevention and control measures for meningococcal disease

Vaccines are available against serogroups A, B, C, Y and W. Most instances of the disease in Europe are caused by serogroups B and C.

Public health management

Publication

Public health guidance on management of sporadic cases of invasive meningococcal disease and their contacts

public health guidance -

Immunisation & childhood vaccination

Questions and answers about childhood vaccination

Publication

Let’s talk about protection: enhancing childhood vaccination uptake

public health guidance -

Publication

Let’s talk about hesitancy: enhancing confidence in vaccination and uptake

technical guidance -

Data

Communication toolkit on immunisation: How to increase immunisation uptake

communication toolkit, tool

Publication

Communication on immunisation – building trust

technical guidance, guide -